HIV Infections
Conditions
Keywords
Cognition, Rehabilitation, Cognitive Stimulation, Human Immunodeficiency Virus, AIDS
Brief summary
There has been little success in treating the cognitive (thinking) problems associated with HIV/AIDS using medications. The purpose of this study is to determine whether an internet-based cognitive stimulation program might help HIV-infected individuals think more clearly. If this is true, then it means that people with mild forms of cognitive impairment may be able to help themselves to get better.
Detailed description
The neurocognitive manifestations of HIV/AIDS have long been recognized as important for the management, survival, and quality of life of affected patients and their families. Following the advent of Highly active anti-retroviral therapy (HAART) the incidence of HIV-associated dementia (HAD) has fallen, but the prevalence of the milder forms of HIV-related cognitive disorders has risen. This is important because alterations in cognitive function can have significant impact on work and social activities, mood, and perceived quality of life. To date, pharmacological management of HIV-associated cognitive disorders - apart from HAART - have met with limited success (e.g., Peptide T, Ritalin). Therefore, it appears reasonable to ask whether the use of non-pharmacological tools might help alleviate or ameliorate the symptoms of the milder forms of cognitive impairment, and thus improve mood and activities of daily living. The purpose of this application is to request funds to allow us to complete a feasibility/pilot study of the merits of using an internet-based cognitive stimulation program (CSP) to improve the cognitive functions and quality of life of individuals with HIV/AIDS, and, secondarily, to detect such changes using a computerized assessment tool designed for use in a health care practitioner's office (Computer-Based Assessment of Mild Cognitive Impairment (CAMCI)).
Interventions
BEHAVIORALSmartbrain
The initial session will be set for 10 minutes, with weekly increases (of 10 minutes) to a maximum of 30 minutes per day, 7 days a week. Each subject will be trained using the same modules of the Smartbrain protocol, with an emphasis on speed of information processing.
Sponsors
National Institute of Mental Health (NIMH)
University of Pittsburgh
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Access to the Internet (either from home or public access) * Native language is English * HIV infected Exclusion Crieria: * Active drug/alcohol abuse or dependence * Current major depression * History of neurological disease, Central Nervous System Opportunistic Infections, tumors, or stroke * History of learning disability or Attention Deficit/Hyperactivity Disorder (by subject report).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global Impairment Rating from battery of neuropsychological tests. | 24 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Change in perceived quality of life using MOS/HIV | 24 weeks |
Countries
United States
Outcome results
None listed